Results 181 to 190 of about 1,205,764 (269)

SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential

open access: yesThe FASEB Journal, Volume 40, Issue 17, 15 September 2026.
SIRT1, an NAD+‐dependent deacetylase, supports cognitive resilience by coordinating neuroprotection, synaptic plasticity, autophagy–lysosomal proteostasis, and mitochondrial energy homeostasis. Reduced or dysregulated SIRT1 is associated with protein aggregation, neuroinflammation, mitochondrial dysfunction, synaptic loss, and cognitive decline in ...
Jiabin Duan   +6 more
wiley   +1 more source

Neuromodulation therapies in the management of tardive dyskinesia: A scoping review. [PDF]

open access: yesIndian J Psychiatry
Kololichalil A   +4 more
europepmc   +1 more source

Cross-Dataset Evaluation of an Automated Video-Based Model for Detecting Tardive Dyskinesia Using the Clinician's Tardive Inventory: Validation Study. [PDF]

open access: yesJMIR Ment Health
Trosch R   +10 more
europepmc   +1 more source

Clinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders. [PDF]

open access: yesSchizophrenia (Heidelb)
Altinok DCA   +12 more
europepmc   +1 more source

Early Treatment of Post-Stroke Spasticity with Botulinum Toxin Type A: Myth or Reality? [PDF]

open access: yesToxins (Basel)
Picelli A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy